Being a complex disease that affects millions of people world over, cancer research has assumed great significance. Translational cancer research transforms scientific discoveries in the laboratory into clinical application to reduce incidence of cancer, morbidity and mortality. On the other hand, personalized medicine in cancer is the concept that selection of a treatment should be tailored according to the individual patient's specific genomic characteristics, including mutations, chromosomal aberrations, protein interactions, and SNPs, and even more, taking into account the inmume system, the metabolism and maybe in the next future also the microbiome. 

Preface

Pharmaco-Geno-Proteo-Metabolomics and Translational Research in Cancer
Next generation sequencing (NGS): a revolutionary technology in pharmacogenomics and personalized medicine in Cancer
Pharmaco-epigenomics: on the road of translation medicine
Design and Implementing Pharmacogenomics Study in Cancer
Onco-omics approaches and applications in Clinical Trials for Cancer patients
Issues and Ethical Considerations in Pharmaco-oncogenomics
Pharma-oncogenomics in the era of personal genomics: a quick guide to online resources and tools
Inmuno-Oncology in the era of Personalized Medicine
CAR T Cell and Personalized Medicine
Oncobiome at the forefront of a novel molecular mechanism to understand the Microbiome and Cancer
Nutrition, Cancer and Personalized Medicine
Index.